Dare Bioscience
DARE
23 hedge funds and large institutions have $2.16M invested in Dare Bioscience in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
0.71% more ownership
Funds ownership: 9.51% → 10.22% (+0.71%)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
4% less funds holding
Funds holding: 24 → 23 (-1)
10% less capital invested
Capital invested by funds: $2.39M → $2.16M (-$229K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$142K |
| 2 |
AE
AMH Equity
Great Neck,
New York
|
+$85.5K |
| 3 |
Raymond James Financial
St Petersburg,
Florida
|
+$4.91K |
| 4 |
Renaissance Technologies
New York
|
+$3.5K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$146 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$20.7K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.31K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$785 |
| 4 |
MG
Mather Group
Chicago,
Illinois
|
-$243 |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$216 |
DARE Hedge Fund Activity: Q2 2025 in Review
23 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q2 2025, worth a combined $2.16M — down 9.6% from $2.39M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of DARE and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 5 added.
The largest buyer was Susquehanna International Group, adding an estimated $142K. The largest seller was UBS Group, cutting an estimated $20.7K.
- 23 institutional investors held Dare Bioscience (DARE) as of Q2 2025, down from 24 in Q1 2025.
- Funds reported $2.16M of Dare Bioscience stock for Q2 2025, down 9.6% quarter-over-quarter.
- 2 funds opened new Dare Bioscience positions in Q2 2025 and 3 closed out, a net change of -1 holder.
- The largest Dare Bioscience buyer in Q2 2025 was Susquehanna International Group, an estimated $142K added.
- The largest Dare Bioscience seller in Q2 2025 was UBS Group, an estimated $20.7K sold.
Based on aggregated 13F filings for Q2 2025.